Therefore, while Tα1 presents vast anti-tumors effects and have been shown synergic effects with multiple anti-cancer therapies (reviewed in section 7), the members of the beta thymosin family can either stimulate or inhibit tumor progression, differentially interfering with prognosis according to the type of cancer. Here, TAAR1 is linked to neoplasm.